BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36337342)

  • 1. Small extracellular vesicles in plasma reveal molecular effects of modified Mediterranean-ketogenic diet in participants with mild cognitive impairment.
    Kumar A; Sharma M; Su Y; Singh S; Hsu FC; Neth BJ; Register TC; Blennow K; Zetterberg H; Craft S; Deep G
    Brain Commun; 2022; 4(6):fcac262. PubMed ID: 36337342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
    Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
    EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer's disease: novel methodology and clinical proof of concept.
    Eitan E; Thornton-Wells T; Elgart K; Erden E; Gershun E; Levine A; Volpert O; Azadeh M; Smith DG; Kapogiannis D
    Extracell Vesicles Circ Nucl Acids; 2023 Mar; 4(1):133-150. PubMed ID: 37842184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.
    Neth BJ; Mintz A; Whitlow C; Jung Y; Solingapuram Sai K; Register TC; Kellar D; Lockhart SN; Hoscheidt S; Maldjian J; Heslegrave AJ; Blennow K; Cunnane SC; Castellano CA; Zetterberg H; Craft S
    Neurobiol Aging; 2020 Feb; 86():54-63. PubMed ID: 31757576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis.
    Li TR; Yao YX; Jiang XY; Dong QY; Yu XF; Wang T; Cai YN; Han Y
    Alzheimers Res Ther; 2022 May; 14(1):66. PubMed ID: 35550625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer's Disease.
    Brinkley TE; Leng I; Register TC; Neth BJ; Zetterberg H; Blennow K; Craft S
    Front Neurosci; 2022; 16():906539. PubMed ID: 35720727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron-derived EVs.
    Nogueras-Ortiz CJ; Eren E; Yao P; Calzada E; Dunn C; Volpert O; Delgado-Peraza F; Mustapic M; Lyashkov A; Rubio FJ; Vreones M; Cheng L; You Y; Hill AF; Ikezu T; Eitan E; Goetzl EJ; Kapogiannis D
    J Extracell Vesicles; 2024 Jun; 13(6):e12459. PubMed ID: 38868956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediterranean Diet, Ketogenic Diet or MIND Diet for Aging Populations with Cognitive Decline: A Systematic Review.
    Devranis P; Vassilopoulou Ε; Tsironis V; Sotiriadis PM; Chourdakis M; Aivaliotis M; Tsolaki M
    Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression within neuronal-derived small extracellular vesicles in frontotemporal degeneration.
    Pounders J; Hill EJ; Hooper D; Zhang X; Biesiada J; Kuhnell D; Greenland HL; Esfandiari L; Timmerman E; Foster F; Wang C; Walsh KB; Shatz R; Woo D; Medvedovic M; Langevin S; Sawyer RP
    Medicine (Baltimore); 2022 Oct; 101(40):e30854. PubMed ID: 36221381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity.
    Fristed E; Skirrow C; Meszaros M; Lenain R; Meepegama U; Papp KV; Ropacki M; Weston J
    Brain Commun; 2022; 4(5):fcac231. PubMed ID: 36381988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer's Disease: a serum and CSF-based metabolic analysis.
    Schweickart A; Batra R; Neth BJ; Martino C; Shenhav L; Zhang AR; Shi P; Karu N; Huynh K; Meikle PJ; Schimmel L; Dilmore AH; Blennow K; Zetterberg H; Blach C; Dorrestein PC; Knight R; ; Craft S; Kaddurah-Daouk R; Krumsiek J
    medRxiv; 2023 Nov; ():. PubMed ID: 38076824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease.
    Chen Y; Therriault J; Luo J; Ba M; Zhang H; Initiative ADN
    J Integr Neurosci; 2021 Dec; 20(4):861-870. PubMed ID: 34997710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of neuronal exosomes in HIV cognitive impairment exposes sex differences.
    Sun B; Fernandes N; Pulliam L
    AIDS; 2019 Sep; 33(11):1683-1692. PubMed ID: 31149942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O
    Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.